Endothelial dysfunction in hypertension

Journal of Nephrology

Volumn 13, Issue 3, 2000, Pages 205-210

  Taddei, Stefano ^a   Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Salvetti, Guido ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Endothelium; Essential hypertension; Nitric oxide; Oxidative stress

Indexed keywords

NITRIC OXIDE;

ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; ESSENTIAL HYPERTENSION; HUMAN; HYPERPOLARIZATION; OXIDATIVE STRESS; THROMBOSIS; VASODILATATION;

ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; NITRIC OXIDE;

EID: 0033936242     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (59)

1. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, Fla CRC Press, 1990; 1-215.
2. Furchgott RF, Zawadzky JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
4. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
5. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714.
6. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145-9.
7. Miller VM, Vanhoutte PM. Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase. Am J Physiol 1985; 248: H432-7.
8. Aldere RJ, Kiritsy-Roy JA, Catravas JD. Acetylcholine-induced contractions in isolated rabbit pulmonary arteries: Role of thromboxane A2. J Pharmacol Exp Ther 1986; 236: 535-41.
9. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989; 257: H33-7.
10. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-6.
11. Lüscher TF, Noll G. Endothelial function as an end-point in interventional trials: concepts, method and current data. J Hypertens 1996; 14 (suppl. 2): S111-21.
12. Linder L, Kiowski W, Buhler FR, Luher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: Blunted response in essential hypertension. Circulation 1990; 81: 1762-7.
13. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
14. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-74.
15. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87: 1475-81.
16. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993; 21: 1145-51.
17. Taddei S, Virdis A, Mattel P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-33.
18. Taddei S, Mattei P, Virdis A, Sudano I, Ghiadoni L, Salvetti A. Effect of potassium on vasodilation to acetylcholine in essential hypertension. Hypertension 1994; 23: 485-90.
19. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994; 24: 499-505.
20. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 1995; 92: 2911-18.
21. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995; 91: 1732-8.
22. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Basile Fasolo C, Sudano I, Salvetti A. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 1995; 91: 1981-7.
23. Taddei S, Virdis A, Ghiadoni L, Mattei P, Bernini GP, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in normotensive and essential hypertensive humans. Hypertension 1996; 28: 576-82.
24. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997; 29 (part 2): 274-9.
25. Rossi M, Taddei S, Fabbri A, Tintori G, Crediddio L, Virdis A, Ghiadoni L, Salvetti A, Giusti C. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 1997; 29: 406-11.
26. Falloon BJ, Haegerty AM. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994; 24: 16-23.
27. Zeiher AM, Drexter H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92: 652-62.
28. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T, Takeshita A. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Hypertension 1995; 25: 201-6.
29. Mimram A, Ribstein J, DuCailar G. Contrasting effects of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995; 26 (part 1): 937-41.
30. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti-Rosei E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28: 7857-90.
31. Frielingsdorf J, Seiler C, Kaufmann P, Vassalli G, Suter T, Hess OM. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation 1996; 93: 1380-7.
32. Antony I, Lerebours G, Nitemberg A. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressure test-induced dilations in coronary arteries of hypertesive patients. Circulation 1996; 94: 197-204.
33. Taddei S, Virdis A, Mattel P, Ghiadoni L, Sudano I, Salvetti A. Defective L-Arginine Nitric Oxide in offspring of essential hypertensive patients. Circulation 1996; 94: 1298-303.
34. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 27: 849-53.
35. Vita JA, Treasure CB, Nabel EG, Melenacham JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-7.
36. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikarni Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990; 81: 482-90.
37. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993; 88: 77-81.
38. Taddei S, Virdis A, Mattel P, Ghiadoni L, Basile-Fasolo C, Sudano I, Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997; 29: 736-43.
39. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97: 2222-9.
40. Garcia CE, Kilcoyne CM, Cardillo C, Cannon III RO, Quyyumi AA, Panza JA. Effect of copper-zinc supeoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertension 1995; 26 (part 1): 863-8.
41. Cardillo C, Kilcoyne CM, Cannon III RO, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997; 30 (part 1): 57-63.
42. Taddei S, Virdis A, Ghiadoni L, Buralli S, Salvetti A. Vasodilation to bradykinin is mediated by hyperpolarization as a compensatory mechanism for impaired NO availability in essential hypertensive patients. (Submitted).
43. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Losealzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 2287-34.
44. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric-oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993; 88: 2541-7.
45. Heitzer T, Y Herttauala S, Luoma J, Kurz S, Mnzel T, Just H, Olschewski M, Drexeler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93: 1346-53.
46. Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA. Impaired nitric oxide mediated vasodilation in patients with non insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27: 567-74.
47. Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 22-8.
48. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-4.
49. Tawakol A, Torbjrn O, Gerhard M, Wu JT, Creager MA. Hyperhomocyst e inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 95: 1119-21.
50. Zeiher AM, Drexler H, Wollshender H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989; 14: 1181-90.
51. Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-46.
52. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-68.
53. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-7.
54. Dubey OB, Lücher TF. Nitric oxide inhibits angiotensin II induced migration of vascular smooth muscle cells. Hypertension 1993; 22: 412.
55. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci USA 1991; 88; 4651-5.
56. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest 1995; 96: 60-8.
57. Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M, Di Venanzio L, Salvetti A. Endothelial function and common carotid wall thickening in essential hypertensive patients. Hypertension 1998, 32: 25-32.
58. Zeiher AM, Schachlinger V, Hohnloser ST, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Circulation 1994; 89: 2525-32.
59. Davis SF, Yeung AC, Meredith IT, Charboneau F, Ganz P, Selawin AP, Anderson TJ. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year post transplant. Circulation 1996; 93: 457-62.